CAS 60325-46-4
:Sulprostone
Description:
Sulprostone is a synthetic prostaglandin E1 analog, primarily used for its pharmacological properties in obstetrics and gynecology. It is characterized by its ability to induce uterine contractions and is often utilized in medical procedures such as labor induction and the management of certain types of abortion. The substance acts by binding to specific prostaglandin receptors, leading to increased smooth muscle activity in the uterus. Sulprostone is typically administered via injection and has a relatively short half-life, necessitating careful dosing and monitoring. Its chemical structure includes a hydroxyl group and a carboxylic acid, contributing to its biological activity. While effective, the use of sulprostone may be associated with side effects such as gastrointestinal disturbances and cardiovascular effects, which require consideration during treatment. As with any medication, its use should be guided by clinical protocols and patient-specific factors to ensure safety and efficacy.
Formula:C23H31NO7S
InChI:InChI=1/C23H31NO7S/c1-32(29,30)24-23(28)12-8-3-2-7-11-19-20(22(27)15-21(19)26)14-13-17(25)16-31-18-9-5-4-6-10-18/h2,4-7,9-10,13-14,17,19-20,22,25,27H,3,8,11-12,15-16H2,1H3,(H,24,28)/t17-,19-,20-,22-/m1/s1
InChI key:InChIKey=UQZVCDCIMBLVNR-TWYODKAFSA-N
SMILES:C(=C/[C@H](COC1=CC=CC=C1)O)\[C@@H]2[C@@H](C/C=C\CCCC(NS(C)(=O)=O)=O)C(=O)C[C@H]2O
Synonyms:- (5Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-buten-1-yl]-5-oxocyclopentyl]-N-(methylsulfonyl)-5-heptenamide
- (5Z)-7-{(1R,2R,3R)-3-Hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxybut-1-en-1-yl]-5-oxocyclopentyl}-N-(methylsulfonyl)hept-5-enamide
- (5Z)-7-{(1R,2R,3R)-3-hydroxy-2-[(1E)-3-hydroxy-4-phenoxybut-1-en-1-yl]-5-oxocyclopentyl}-N-(methylsulfonyl)hept-5-enamide
- 5-Heptenamide, 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-butenyl]-5-oxocyclopentyl]-N-(methylsulfonyl)-, (5Z)-
- 5-Heptenamide, 7-[3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl]-N-(methylsulfonyl)-, [1R-[1α(Z),2β(1E,3R*),3α]]-
- 5-heptenamide, 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-buten-1-yl]-5-oxocyclopentyl]-N-(methylsulfonyl)-, (5Z)-
- 60325-46-4
- 7-[(1R,2R,3R)-3-hydroxy-2-[(3R)-3-hydroxy-4-phenoxy-but-1-enyl]-5-oxo-cyclopentyl]-N-methylsulfonyl-hept-5-enamide
- Cp 34089
- Nalador
- Shb 286
- Zk 57671
- [1R-[1a(Z),2b(1E,3R*),3a]]-7-[3-Hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl]-N-(methylsulfonyl)-5-heptenamide
- Sulprostone
- (5z,11α,13e,15r)-11,15-dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranorprosta-5,13-dienoic acid methane sulfonamide
- 5-heptenamide,7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)
- Sulprostone USP/EP/BP
- N-(METHYLSULFONYL)-9-OXO-11ALPHA,15R-DIHYDROXY-16-PHENOXY-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-AMIDE
- (5Z,11alpha,13E,15R)-11,15-Dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranor-prosta-5Z,13E-dien-1-amide
- (5Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3R)-3-hydroxy-4-buten-1-yl]-5-oxocyclopentyl]-N-(methylsulfonyl)-5-heptenamide
- CP-34089, SHB-286, ZK-57671, (5Z,11α,13E,15R)--11,15-Dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranorprosta-5,13-dienoic acid methane sulfonamide
- 16-phenoxy-omega-17,18,19,20-tetranorpge-2methylsulfonylamide
- sch286
- 16-phenoxy-omega-17,18,19,20-tetranorprostaglandine2methylsulfonylamide
- (1r-(1-alpha(z),2-beta(1e,3r*),3-alpha))--n-(methylsulfonyl)
- (5Z,11ALPHA,13E,15R)-11,15-DIHYDROXY-9-OXO-16-PHENOXY-17,18,19,20-TETRANORPROSTA-5,13-DIENOIC ACID METHANE SULFONAMIDE
- 16-phenoxy-17,18,19,20tetranorprostaglandine(sub2)methylsulfonylamide
- CP-34086
- (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3R)-3-hydroxy-4-(phenoxy)but-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide
- (5Z,11a,13E,15R)--11,15-Dihydroxy-9-oxo-16-phenoxy-17,18,19,20-tetranorprosta-5,13-dienoic acid methane sulfonamide
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Sulprostone
CAS:EP3 and EP1 receptor agonistFormula:C23H31NO7SPurity:98%Color and Shape:White To Off-White SolidMolecular weight:465.56

